New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 8, 2013
09:37 EDTCAP, ARIA, VSTM, MDR, AFFY, MSI, ZBRA, PCYC, ALNY, CENT, MUX, PAY, ONXX, CELGOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Affymax (AFFY) initiated with an Outperform at JMP Securities... Alnylam (ALNY) initiated with an Outperform at JMP Securities... Celgene (CELG) initiated with an Outperform at JMP Securities... DSW (DSW) initiated with a Buy at Sterne Agee... McDermott (MDR) initiated with a Neutral at HSBC... Onyx Pharmaceuticals (ONXX) initiated with an Outperform at JMP Securities... Pharmacyclics (PCYC) initiated with an Outperform at JMP Securities... Verastem (VSTM) initiated with an Outperform at JMP Securities... VeriFone (PAY) initiated with a Hold at Jefferies... sZebra Technologies (ZBRA) initiated with a Market Perform at Wells Fargo... ARIAD (ARIA) initiated with an Outperform at JMP Securities... McEwen Mining (MUX) initiated with a Buy at Stifel Nicolaus... Motorola Solutions (MSI) initiated with an Outperform at Wells Fargo... CAI International (CAP) initiated with an Outperform at Wells Fargo... Central Garden & Pet (CENT) initiated with a Neutral at SunTrust.
News For AFFY;CELG;ALNY;MDR;ONXX;PCYC;VSTM;PAY;ZBRA;ARIA;MUX;MSI;CAP;CENT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
August 26, 2015
08:33 EDTZBRAZebra Technologies initiated with an Outperform at Barrington
Subscribe for More Information
08:07 EDTZBRAZebra Technologies launches new time tracking myocardial solution
Zebra Technologies and Leiden University Medical Center in Leiden, the Netherlands announced the first commercial deployment of the Time Tracking Solution for Acute Myocardial Infarction Patients. The technology will be shared for the first time during the European Society for Cardiology Congress in London. Zebra Technologies worked with LUMC to develop a solution powered by Zatar, Zebra's Internet of Things platform to enable hospitals to track patients and provide real-time feedback on Door-To-Balloon time.
07:09 EDTALNYVertex, Novavax among select biotechs to buy on weakness, says Piper Jaffray
Subscribe for More Information
August 25, 2015
09:59 EDTPAYOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:33 EDTPAYVerifone upgraded to Overweight from Neutral at Piper Jaffray
Subscribe for More Information
07:31 EDTCELGCelgene announces expiration of tender offer for Receptos shares
Subscribe for More Information
August 24, 2015
18:55 EDTCELGOn The Fly: After Hours Movers
Subscribe for More Information
18:52 EDTCELGJazz, Celgene, Shire up after USPTO rejects Acorda patent challenge
Subscribe for More Information
13:36 EDTCELGBiotech correction presents some opportunities, says RBC Capital
RBC Capital analyst Michael Yee said he won't try to pick the short-term bottom in biotech, but contends that any macro weakness in China shouldn't have any major impact to financials or fundamentals for the sector given their minimal exposure there. If the market continues to be volatile, Yee recommends a focus on names with defensive characteristics, such as higher margins and free cash flow yield, naming Amgen (AMGN), Celgene (CELG) and Gilead (GILD) as some examples. The analyst adds that he likes Vertex (VRTX) on the pullback for "more aggressive" growth investors. Yee has Outperform ratings on all of the stocks mentioned above.
11:43 EDTALNYThe Medicines Co. and Alnylam Pharmaceuticals hold a joint conference call
Subscribe for More Information
09:45 EDTZBRAOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:05 EDTZBRAZebra Technologies initiated with an Overweight at Morgan Stanley
Subscribe for More Information
August 23, 2015
12:35 EDTCELGBiotech firms could see 'billions' in sales from new cancer drugs, Barron's says
Subscribe for More Information
August 20, 2015
07:57 EDTZBRAHuron names Debbie Murphy as Chief Marketing Officer
Subscribe for More Information
07:31 EDTALNYAlnylam Pharmaceuticals to hold a roundtable
Final Roundtable in a series of online "RNAi Roundtables" entitled, "Patisiran & Revusiran for Treatment of Transthyretin (TTR)-Mediated Amyloidosis", consisting of presentations by Alnylam scientists, clinical collaborators and patient advocates review recent progress in many of the company's development-stage pipeline programs will be held on August 20 at 9 am. Webcast Link
05:48 EDTVSTMMizuho keeps TESARO, Verastem, OncoMed as top biotech picks
Subscribe for More Information
August 18, 2015
14:02 EDTMSIMotorola Solutions files automatic mixed securities shelf
Subscribe for More Information
13:12 EDTMSIMotorola Solutions in late stage talks to buy Airwave Solutions, Bloomberg says
According to people with knowledge of the matter, Motorola Solutions is in late stage talks to acquire U.K. communication services provider Airwave Solutions, Bloomberg reports. Reference Link
August 17, 2015
06:38 EDTMSIApple Watch revenue leader in wearable category, Business Insider reports
Subscribe for More Information
06:22 EDTALNYPiper's Tenthoff sees select biotech names outperforming in second half
Piper Jaffray analyst Edward Tenthoff expects drug launches, clinical data read-outs and potential partnerships to drive outperformance for select biotech names in the second half of 2015. Despite some recent profit-taking, 2015 has been another strong year for biotech stocks, Tenthoff tells investors in a research note. Names with important second half of the year catalysts include Vertex (VRTX), Regeneron (REGN), Seattle Genetics (SGEN), Exelixis (EXEL), Sarepta (SRPT), Novavax (NVAX), Arrowhead (ARWR), Array BioPharma (ARRY), Alnylam (ALNY), Genocea (GNCA), CymaBay (CBAY), Idera Pharmaceuticals (IDRA), Vitae Pharmaceuticals (VTAE).
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use